A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.
SHELTON, CT / ACCESS Newswire / January 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC) (the 'Company') today announced that it has engaged a Clinical Research Organization (CRO) to conduct a ...
All subjects have now been enrolled in Island Pharmaceutical’s phase 2b arm of its ISLA-101 trial in dengue fever. Don't miss out on the headlines from Stockhead. Followed categories will be added to ...